Actively Recruiting
Universal Rare Gene Study of Retinal Dystrophies with Rare Genetic Variants A Registry and Longitudinal Natural History Study
Led by Jaeb Center for Health Research · Updated on 2026-10-29
1500
Participants Needed
36
Research Sites
52 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are conducting an international, multicenter observational study to better understand retinal dystrophies linked to rare disease-causing genetic variants. The study has two main parts a Registry and a Natural History Study. The Registry collects standardized genetic and clinical data across many rare genes related to retinal dystrophy, while the Natural History Study prospectively follows participants over time to track disease progression and identify outcome measures. Participants first undergo a screening phase where their existing genetic test reports are reviewed to confirm eligibility. Those enrolled in the Registry may receive annual phone calls up to four years unless their gene is selected for the Natural History Study, in which case they will have clinic visits for baseline and follow-up assessments. The Natural History Study aims to describe disease progression, link structural and functional eye changes, and identify subgroups for future clinical trials. During the study, participants will complete various eye tests and imaging assessments at baseline and yearly visits for up to four years. Functional outcomes measured include visual field sensitivity, visual acuity, retinal sensitivity, contrast sensitivity, retinal responses, color vision, and structural changes in retinal layers. This comprehensive evaluation will help researchers understand how retinal dystrophies develop and progress, supporting future research and treatment development.
CONDITIONS
Brief Title
Universal Rare Gene Study: A Registry and Natural History Study of Retinal Dystrophies Associated With Rare Disease-Causing Genetic Variants
Research Team
C
Coordinating Center
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here